219 related articles for article (PubMed ID: 12112671)
21. Design of an optimized scaffold for affibody molecules.
Feldwisch J; Tolmachev V; Lendel C; Herne N; Sjöberg A; Larsson B; Rosik D; Lindqvist E; Fant G; Höidén-Guthenberg I; Galli J; Jonasson P; Abrahmsén L
J Mol Biol; 2010 Apr; 398(2):232-47. PubMed ID: 20226194
[TBL] [Abstract][Full Text] [Related]
22. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro.
Jonsson A; Wållberg H; Herne N; Ståhl S; Frejd FY
Biotechnol Appl Biochem; 2009 Aug; 54(2):93-103. PubMed ID: 19545237
[TBL] [Abstract][Full Text] [Related]
23. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
[TBL] [Abstract][Full Text] [Related]
24. Monitored whole gene in vitro evolution of an anti-hRaf-1 affibody molecule towards increased binding affinity.
Grimm S; Salahshour S; Nygren PÅ
N Biotechnol; 2012 Jun; 29(5):534-42. PubMed ID: 22027369
[TBL] [Abstract][Full Text] [Related]
25. Simplified characterization through site-specific protease-mediated release of affinity proteins selected by staphylococcal display.
Kronqvist N; Löfblom J; Severa D; Ståhl S; Wernérus H
FEMS Microbiol Lett; 2008 Jan; 278(1):128-36. PubMed ID: 18034830
[TBL] [Abstract][Full Text] [Related]
26. Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling.
Gunneriusson E; Nord K; Uhlén M; Nygren P
Protein Eng; 1999 Oct; 12(10):873-8. PubMed ID: 10556248
[TBL] [Abstract][Full Text] [Related]
27. Generation of Affibody ligands binding interleukin-2 receptor alpha/CD25.
Grönwall C; Snelders E; Palm AJ; Eriksson F; Herne N; Ståhl S
Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):97-112. PubMed ID: 18284375
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.
Mume E; Orlova A; Larsson B; Nilsson AS; Nilsson FY; Sjöberg S; Tolmachev V
Bioconjug Chem; 2005; 16(6):1547-55. PubMed ID: 16287254
[TBL] [Abstract][Full Text] [Related]
29. Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain.
Starovasnik MA; O'Connell MP; Fairbrother WJ; Kelley RF
Protein Sci; 1999 Jul; 8(7):1423-31. PubMed ID: 10422830
[TBL] [Abstract][Full Text] [Related]
30. Conformational stabilization of an engineered binding protein.
Wahlberg E; Härd T
J Am Chem Soc; 2006 Jun; 128(23):7651-60. PubMed ID: 16756322
[TBL] [Abstract][Full Text] [Related]
31. Fine affinity discrimination by normalized fluorescence activated cell sorting in staphylococcal surface display.
Löfblom J; Wernérus H; Ståhl S
FEMS Microbiol Lett; 2005 Jul; 248(2):189-98. PubMed ID: 15964717
[TBL] [Abstract][Full Text] [Related]
32. A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.
Kronqvist N; Löfblom J; Jonsson A; Wernérus H; Ståhl S
Protein Eng Des Sel; 2008 Apr; 21(4):247-55. PubMed ID: 18239074
[TBL] [Abstract][Full Text] [Related]
33. An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein.
Hansson M; Ringdahl J; Robert A; Power U; Goetsch L; Nguyen TN; Uhlén M; Ståhl S; Nygren PA
Immunotechnology; 1999 Mar; 4(3-4):237-52. PubMed ID: 10231093
[TBL] [Abstract][Full Text] [Related]
34. Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
Löfdahl PA; Nord O; Janzon L; Nygren PA
N Biotechnol; 2009 Nov; 26(5):251-9. PubMed ID: 19576305
[TBL] [Abstract][Full Text] [Related]
35. Engineering of affibody molecules for therapy and diagnostics.
Feldwisch J; Tolmachev V
Methods Mol Biol; 2012; 899():103-26. PubMed ID: 22735949
[TBL] [Abstract][Full Text] [Related]
36. Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies.
Lipovsek D; Lippow SM; Hackel BJ; Gregson MW; Cheng P; Kapila A; Wittrup KD
J Mol Biol; 2007 May; 368(4):1024-41. PubMed ID: 17382960
[TBL] [Abstract][Full Text] [Related]
37. The use of gene fusions to protein A and protein G in immunology and biotechnology.
Ståhl S; Nygren PA
Pathol Biol (Paris); 1997 Jan; 45(1):66-76. PubMed ID: 9097850
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions.
O'Seaghdha M; van Schooten CJ; Kerrigan SW; Emsley J; Silverman GJ; Cox D; Lenting PJ; Foster TJ
FEBS J; 2006 Nov; 273(21):4831-41. PubMed ID: 16999823
[TBL] [Abstract][Full Text] [Related]
39. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
[TBL] [Abstract][Full Text] [Related]
40. Thermodynamics of folding, stabilization, and binding in an engineered protein--protein complex.
Dincbas-Renqvist V; Lendel C; Dogan J; Wahlberg E; Härd T
J Am Chem Soc; 2004 Sep; 126(36):11220-30. PubMed ID: 15355103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
